While agencies such as the American Cancer Society and the American Urological Association recommend that physicians offer PSA and DRE testing to men 50 years and older who have a life expectancy of at least 10 years, and to younger men who are at high risk, they stress the need for them to provide men with adequate information regarding the potential benefits, side effects and uncertainties regar